Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Human Urinary Kallikrein in Acute Cerebral Infarction
NCT02562183Phase 4Unknown
- Sponsor
- Guangdong Techpool Bio-pharma
- Start
- Aug 2015
- Primary completion
- Nov 2018
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Human urinary kallidinogenase in cerebral infarction, sponsored by Guangdong Techpool Bio-pharma. Status: unknown.
02
Drugs
Human urinary kallidinogenase
03
Conditions
cerebral infarction
Beyond the preview
Go deeper on NCT02562183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02562183.